6533b825fe1ef96bd1282089
RESEARCH PRODUCT
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma.
Giuseppe BadalamentiGiuseppe PerroneAngelo Paolo Dei TosAlfonso BaldiPaolo G. CasaliRoberta SanfilippoDaniele SantiniGiuseppe ToniniAndrea Onetti-mudaSilvia StacchiottiMichele IulianiPaola ColliniFrancesco PantanoBruno VincenziAlessandro Gronchisubject
LeiomyosarcomaDrugCancer Researchbiologybusiness.industrymedia_common.quotation_subjectTransporterEquilibrative nucleoside transporter 1medicine.diseaseGemcitabineOncologybiology.proteinCancer researchMedicineAngiosarcomaSarcomabusinessmedicine.drugmedia_commondescription
11062Background: Human equilibrative nucleoside transporter 1 (hENT1) is the major gemcitabine transporter into cells. Gemcitabine is an active drug in different sarcoma subtypes including leiomyos...
year | journal | country | edition | language |
---|---|---|---|---|
2016-05-20 | Journal of Clinical Oncology |